Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

China flag China · Delayed Price · Currency is CNY
4.900
+0.100 (2.08%)
At close: Mar 10, 2026
36.87%
Market Cap 5.20B
Revenue (ttm) 2.49B
Net Income (ttm) -677.20M
Shares Out 1.06B
EPS (ttm) -0.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,985,360
Average Volume 19,051,704
Open 4.830
Previous Close 4.800
Day's Range 4.820 - 4.930
52-Week Range 3.280 - 6.740
Beta 0.50
RSI 51.39
Earnings Date Mar 16, 2026

About SHE:002793

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and chan... [Read more]

Sector Healthcare
Founded 1998
Employees 3,196
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002793
Full Company Profile

Financial Performance

In 2024, SHE:002793's revenue was 2.65 billion, an increase of 11.99% compared to the previous year's 2.36 billion. Losses were -965.50 million, 46.0% more than in 2023.

Financial Statements

News

There is no news available yet.